Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.625 USD | -1.88% | -19.32% | +486.73% |
05-30 | FDA Grants Candel Therapeutics' CAN-3110 Orphan Drug Designation to Treat Recurrent High-Grade Glioma | MT |
05-30 | Candel Therapeutics Gets FDA's Orphan-Drug Status for Glioma Treatment | DJ |